{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:03:17Z","timestamp":1710248597085},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00347-004-1150-x","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T08:25:08Z","timestamp":1107851108000},"page":"230-234","source":"Crossref","is-referenced-by-count":22,"title":["Ergebnisse der ?Ocular hypertension treatment study? (OHTS)"],"prefix":"10.1007","volume":"102","author":[{"given":"N.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(01)00760-6","volume":"108","author":"Brandt","year":"2001","unstructured":"Brandt JD, Beiser JA, Kass MA et al. (2001) Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 108:1779?1788","journal-title":"Ophthalmology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0161-6420(89)32688-1","volume":"96","author":"Epstein","year":"1989","unstructured":"Epstein DL, Krug JH, Hertzmark E, Remis LL, Edelstein DJ (1989) A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 96:1460?1467","journal-title":"Ophthalmology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9394(01)01338-1","volume":"133","author":"Feuer","year":"2002","unstructured":"Feuer WJ, Parrish RK, Schiffmann JC et al. (2002) The Ocular Hypertension Treatment Study: reproducibility of cup disc ratio measurements over time at on optic disc reading center. Am J Ophthalmol 133:19?28","journal-title":"Am J Ophthalmol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"Gordon","year":"2002","unstructured":"Gordon MO, Beiser JA, Brandt JD et al. (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714?720","journal-title":"Arch Ophthalmol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","volume":"117","author":"Gordon","year":"1999","unstructured":"Gordon MO, Kass MA (1999) The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 117:573?583","journal-title":"Arch Ophthalmol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s004170000189","volume":"238","author":"Heijl","year":"2000","unstructured":"Heijl A, Bengtsson B (2000) Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial. Graefes Arch Clin Exp Ophthalmol 238:877?883","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0161-6420(01)00948-4","volume":"109","author":"Johnson","year":"2002","unstructured":"Johnson CA, Keltner JL, Cello KE et al. (2002) Baseline visual field characteristics in the Ocular Hypertension Treatment Study. Ophthalmology 109:432?437","journal-title":"Ophthalmology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/archopht.1989.01070020668025","volume":"107","author":"Kass","year":"1989","unstructured":"Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolder AE, Hart WM, Becker B (1989) Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol 107:1590?1598","journal-title":"Arch Ophthalmol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ et al. (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701?713; discussion 829?830","journal-title":"Arch Ophthalmol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archopht.118.9.1187","volume":"118","author":"Keltner","year":"2000","unstructured":"Keltner JL, Johnson CA, Quigg JM et al. (2000) Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol 118:1187?1194","journal-title":"Arch Ophthalmol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archopht.120.6.829","volume":"120","author":"Palmberg","year":"2002","unstructured":"Palmberg P (2002) Answers from the Ocular Hypertension Treatment Study (editorial). Arch Ophthalmol 120:829?830","journal-title":"Arch Ophthalmol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-9394(00)00527-4","volume":"130","author":"Piltz","year":"2000","unstructured":"Piltz J, Gross R, Shin DH et al. (2000) Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the Ocular Hypertension Treatment Study. Am J Ophthalmol 130:441?453","journal-title":"Am J Ophthalmol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0161-6420(91)32296-6","volume":"98","author":"Schulzer","year":"1991","unstructured":"Schulzer M, Drance SM, Douglas GR (1991) A comparison of treated and untreated glaucoma suspects. Ophthalmology 98:301?307","journal-title":"Ophthalmology"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-004-1150-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-004-1150-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:46:34Z","timestamp":1559051194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-004-1150-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1007\/s00347-004-1150-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}